British Columbia source: bounded use
Epistaxis – Diagnosis and Treatment supplies a Canadian implementation example for this summary. It must not be presented as the rule outside British Columbia.
sources for this section:ECBC epistaxis
Source-attributed clinical priorities
- Assess airway and hemodynamic stability, anticoagulants and bleeding severity before local treatment.
- Use firm continuous compression, clear visualization and a stepwise cautery or packing approach appropriate to the bleeding site.
- Escalate posterior, uncontrolled or recurrent unilateral bleeding and arrange monitoring after posterior packing.
- Time uninterrupted nasal compression with the patient leaning forward before declaring first aid unsuccessful.
sources for this section:ECBC epistaxis
Practical assessment and management workflow
1
Assess airway, blood loss, hemodynamics, anticoagulants, trauma and recurrent unilateral symptoms.
2
Clear clots and identify an anterior source with lighting and suction when trained.
3
Use topical vasoconstrictor, cautery or packing in a stepwise manner and correct significant coagulopathy appropriately.
4
Observe after control and arrange follow-up for recurrent, posterior or suspicious bleeding.
sources for this section:ECBC epistaxis
Safety, red flags and urgent escalation
- Airway compromise, shock or uncontrolled posterior bleeding needs emergency otolaryngology support.
- Do not cauterize both sides of the septum at the same level because perforation risk increases.
- Review posterior-pack monitoring and toxic-shock precautions under the local protocol.
sources for this section:ECBC epistaxis
Confirm the local pathway before acting
British Columbia is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient’s province or territory.
sources for this section:ECBC epistaxis
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:ECBC epistaxis
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Emergency Care BCEpistaxis – Diagnosis and Treatmentaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.